Similar articles

• The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.

  Boers M, Tugwell P. Boers M, et al. J Rheumatol. 1993 Mar;20(3):568-74. J Rheumatol. 1993. PMID: 8478876
• OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.

  Tugwell P, Boers M. Tugwell P, et al. J Rheumatol. 1993 Mar;20(3):528-30. J Rheumatol. 1993. PMID: 8478864 Review. No abstract available.
• A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process.

  Fried BJ, Boers M, Baker PR. Fried BJ, et al. J Rheumatol. 1993 Mar;20(3):548-51. J Rheumatol. 1993. PMID: 8478870 Review.
• European preferences in assessing rheumatoid arthritis.

  Scott DL. Scott DL. J Rheumatol. 1993 Mar;20(3):542. J Rheumatol. 1993. PMID: 8478867 No abstract available.
• Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care.

  Pincus T, Sokka T. Pincus T, et al. Rheum Dis Clin North Am. 2004 Nov;30(4):725-51, vi. doi: 10.1016/j.rdc.2004.08.001. Rheum Dis Clin North Am. 2004. PMID: 15488690 Review.